Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Income towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesResearch & DevelopmentShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intelligent Bio Solutions (INBS) Research & Development (2019 - 2025)

Intelligent Bio Solutions has reported Research & Development over the past 6 years, most recently at $750094.0 for Q2 2024.

  • For Q2 2024, Research & Development rose 490.34% year-over-year to $750094.0; the TTM value through Jun 2024 reached $1.7 million, up 229.86%, while the annual FY2024 figure was $1.7 million, 229.86% up from the prior year.
  • Research & Development for Q2 2024 was $750094.0 at Intelligent Bio Solutions, up from $471313.0 in the prior quarter.
  • Over five years, Research & Development peaked at $2.6 million in Q4 2021 and troughed at -$58825.0 in Q1 2020.
  • A 5-year average of $455716.3 and a median of $320859.0 in 2020 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: plummeted 99.95% in 2022 and later surged 29157.09% in 2023.
  • Year by year, Research & Development stood at $341820.0 in 2020, then soared by 672.68% to $2.6 million in 2021, then plummeted by 99.95% to $1191.0 in 2022, then surged by 29157.09% to $348452.0 in 2023, then skyrocketed by 115.26% to $750094.0 in 2024.
  • Business Quant data shows Research & Development for INBS at $750094.0 in Q2 2024, $471313.0 in Q1 2024, and $348452.0 in Q4 2023.